SCHEMBL26512490

SCHEMBL26512490

N=C1NN=C(N)/C1=N/Nc1ccccc1N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
TP53 P04637 1/20 0.31
APP P05067 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
SNCA P37840 1/20 0.31
BLM P54132 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14645039 0.65 GAA (0.46) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL14304537 0.61 GAA (0.46) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL25291704 0.59 RAB9A (0.36) GAAKDM4EMAPTALDH1A1MEN1
SCHEMBL922338 0.59 MAPT (0.41) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL921350 0.59 KMT2A (0.47) KDM4EMAPTALDH1A1LMNAMEN1
SCHEMBL924008 0.59 L3MBTL1 (0.38) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL3790739 0.57
SCHEMBL2677107 0.57 MAPT (0.71) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL1335991 0.57 MAPT (0.56) GAAKDM4EMAPTALDH1A1LMNA
SCHEMBL924093 0.56 L3MBTL1 (0.44) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES GMPS, PDE11A, CGAS GAA 637/4885KDM4E 3703/4885MAPT 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.